Feasibility of 18 F‐DOPA and 18 F‐FDG PET/CT for guiding decision‐making for localized incidental neuroblastoma in infants under 18 months of age

Documenti analoghi

• Assessment of Lung Nodules in Children With Pediatric Sarcoma Undergoing [18F]‐FDG‐PET/MR for Staging
  di: Giulia Fichera, et al.
  Pubblicazione: (2025)
• Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma
  di: Ya‐Hsuan Chang, et al.
  Pubblicazione: (2024)
• Single centre experience of the use of emicizumab in previously untreated and minimally treated patients under 18 months of age
  di: Eman Hassan, et al.
  Pubblicazione: (2024)
• Spontaneous regression of a greater than 5 cm infant neuroblastoma after a three‐fold volume increase without life‐ or organ‐threatening features
  di: Andrew C. Hinchliffe, et al.
  Pubblicazione: (2024)
• 18F‐FAPI versus 18F‐FDG PET/CT in the Diagnosis of Relapsing Polychondritis
  di: Xiaotong Guo, et al.
  Pubblicazione: (2024)